Example: Heart Attack

Search clinical trials for: Keratolytic Agents

Total 510 results

NCT04468464

Active, not recruiting

Quantitative Evaluation of Osteopathic Treatment in Temporomandibular Joint Disorders Using Magnetic Resonance Imaging

Conditions: Temporomandibular Disorders, Articular Disc Disorder (Reducing or Non-Reducing); Osteopathy in Temporomandibular Disorders
NCT04456946

Recruiting

Prospective Investigation of the Effects of Different Treatment Techniques on Myofascial Trigger Points in Patients With Temporomandibular Dysfunction (TMD)

Conditions: Low Level Laser and Occlusal Splint
NCT04437225

Recruiting

Renal Metabolism of Glycolate to Oxalate

Conditions: Healthy
NCT04433169

Recruiting

All-trans Retinoic Acid (ATRA) in the Treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck

Conditions: Adenoid Cystic Carcinoma of the Head and Neck
NCT04430426

Not yet recruiting

Heterozygous Individuals for AGXT and Kidney Stones

Conditions: Kidney Stone
NCT04417348

Completed

Opsin Receptors in Melasma

Conditions: Melasma
NCT04396067

Not yet recruiting

Combination With Inhibitor of Neutrophil Elastase (All-trans Retinoic Acid ) and Isotretinoin May Enhances Neutralizing Antibodies in COVID -19 Infected Patients Better Than COVID-19 Inactivated Vaccines

Conditions: COVID -19
NCT04385277

Not yet recruiting

Treatment With Dinutuximab in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma

Conditions: Ganglioneuroblastoma, Nodular; High-Risk Neuroblastoma
NCT04382950

Not yet recruiting

Combination of Recombinant Bacterial ACE2 Receptors -Like Enzyme of B38-CAP and Isotretinoin Could be Promising COVID-19 Infection- and Lung Injury Preventing Drug Better Than Recombinant Human ACE2

Conditions: COVID
NCT04372927

Not yet recruiting

ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy

Conditions: Locally Advanced Lung Non-Small Cell Carcinoma; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8
NCT04369222

Recruiting

The Copenhagen Analgesic Study

Conditions: Gonad Regulating Hormone Adverse Reaction; Analgesic Adverse Reaction
NCT04366869

Active, not recruiting

Which is More Effective in Management of Bruxism: Botox or Occlusal Splints

Conditions: Bruxism
NCT04363762

Completed

An Internet-based Multimodal Pain Program for Chronic Temporomandibular Disorder Pain

Conditions: Chronic Pain; Temporomandibular Disorder
NCT04359485

Active, not recruiting

New Score for Pseudo- Acanthosis Nigricans

Conditions: Pseudo Acanthosis Nigricans
NCT04358003

Recruiting

Plasma Adsorption in Patients With Confirmed COVID-19

Conditions: Respiratory Failure; ARDS
NCT04353180

Not yet recruiting

Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 (Randomized)

Conditions: COVID19
NCT04322318

Not yet recruiting

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Conditions: Anaplastic Kidney Wilms Tumor; Recurrent Kidney Wilms Tumor; Stage II Kidney Wilms Tumor; Stage III Kidney Wilms Tumor; Stage IV Kidney Wilms Tumor
NCT04314336

Active, not recruiting

The Economic Impact of Clinical Pharmacist Involvement in the Public Procurement for Medicines and in the Drug and Therapeutics Committee

Conditions: Rationalization
NCT04301076

Not yet recruiting

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATL)

Conditions: Acute Adult T-Cell Leukemia/Lymphoma; Adult T-Cell Leukemia/Lymphoma; Chronic Adult T-Cell Leukemia/Lymphoma; HTLV-1 Infection
NCT04295902

Recruiting

Laryngoscopy for Neonatal and Infant aIrway Management (Optimise-Trial)

Conditions: Airway Management
NCT04293562

Not yet recruiting

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Conditions: Acute Myeloid Leukemia
NCT04282668

Not yet recruiting

A Study of TAS1440 With ATRA in Subjects With r/r AML

Conditions: Acute Myeloid Leukemia
NCT04245319

Recruiting

Combined Effect of Acitretin and nbUVB on Vitiligo Repigmentation

Conditions: Hyperlipidemias; Xerosis; Depression; Liver Diseases
NCT04239859

Not yet recruiting

Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis

Conditions: Plaque Psoriasis
NCT04241276

Not yet recruiting

Phase IIb Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer

Conditions: Pancreatic Cancer
NCT04234048

Not yet recruiting

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Conditions: T-cell Lymphoma; Cutaneous/Peripheral T-Cell Lymphoma; Peripheral T-cell Lymphoma; Peripheral T-Cell Lymphoma, Not Classified; Primary Cutaneous T-cell Lymphoma; Cutaneous T-Cell Lymphoma, Unspecified; Cutaneous T-cell Lymphoma; Follicular T-Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Sézary's Disease; Mycosis Fungoides
NCT04229381

Recruiting

Resiliency Among Older Adults Receiving Lung Cancer Treatment

Conditions: Advanced Lung Carcinoma; Extensive Stage Lung Small Cell Carcinoma; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8; Unresectable Lung Carcinoma; Unresectable Lung Non-Small Cell Carcinoma
NCT04231877

Not yet recruiting

Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Untreated Aggressive Large B-cell Lymphoma

Conditions: Aggressive Non-Hodgkin Lymphoma; ALK-Positive Large B-Cell Lymphoma; B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Primary Mediastinal (Thymic) Large B-Cell Lymphoma; T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
NCT04217148

Recruiting

The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Conditions: Immune Thrombocytopenia
NCT04189302

Not yet recruiting

Comparative Evaluation of Two Surgical Blades

Conditions: Wound Healing
NCT04186897

Completed

Occlusal Reduction Effect on Postendodontic Pain

Conditions: Symptomatic Irreversible Pulpitis
NCT04177004

Not yet recruiting

Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

Conditions: Allogeneic Hematopoietic Stem Cell Transplant Recipient; Hematopoietic and Lymphoid Cell Neoplasm
NCT04175587

Not yet recruiting

Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APL

Conditions: Acute Promyelocytic Leukaemia
NCT04139304

Recruiting

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Conditions: Ann Arbor Stage I Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Plasmablastic Lymphoma
NCT04116255

Completed

Effects of Occlusal Splint and Therapeutic Home Exercises

Conditions: Quality of Life; Neuropathic Pain; Somatic Pain
NCT04116359

Not yet recruiting

Testing of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide and Cisplatin) for Patients With NUT Carcinoma

Conditions: Metastatic NUT Carcinoma; Unresectable NUT Carcinoma
NCT04113863

Recruiting

ATRA Trial - ACTIVITY OF ATRA IN COMBINATION WITH ANASTROZOLE IN PRE-OPERATIVE PHASE OF OPERABLE HR-POSITIVE/HER2-NEGATIVE EARLY BREAST CANCER eBC ATRA TRIAL

Conditions: Breast Neoplasm Female
NCT04096742

Not yet recruiting

Altreno for Chest Rejuvenation

Conditions: Photodamaged Skin; Photoaging
NCT04092283

Recruiting

Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Conditions: Recurrent Lung Non-Small Cell Carcinoma; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Unresectable Lung Non-Small Cell Carcinoma
NCT04080869

Not yet recruiting

Retinyl Palmitate-loaded Ethosomes in Acne Vulgaris

Conditions: Facial Acne Vulgaris
NCT04071756

Recruiting

Topical Tazarotene Vs Placebo In Hand-Foot-Skin Reactions

Conditions: Solid Tumor; Hand-Foot Skin Reaction (HFSR)
NCT04059523

Completed

MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3

Conditions: Acne Vulgaris
NCT04054674

Not yet recruiting

Clinical Performance Of Lithium Disilicate Crowns Restoring Endodontically Treated Teeth With Two Occlusal Preparation Schemes

Conditions: Fracture of Lithium Disilicate (e.Max) Crowns
NCT04052490

Not yet recruiting

Evaluation Of Zirconia Crowns Restoring Endodontically Treated Posterior Teeth With Two Finish Line Designs And Occlusal Reduction Schemes.

Conditions: Gingival Inflammation
NCT04015700

Not yet recruiting

Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Conditions: Glioblastoma
NCT04002024

Recruiting

Moisturizer Containing Licochalcone A, Decanediol, L-carnitine and Salicylic Acid in Reducing Relapsing of Acne

Conditions: Acne Vulgaris; Acne
NCT03999684

Recruiting

A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma

Conditions: Adenoid Cystic Carcinoma
NCT03999866

Completed

Preoperative Assessment of Difficult Laryngoscopy Using Different Videolaryngoscopes

Conditions: Assessment; Difficult Airway Intubation; Preoperative
NCT03991884

Recruiting

Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia

Conditions: Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma
NCT03984448

Recruiting

Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas

Conditions: Diffuse Large B-Cell Lymphoma; Double-Expressor Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present